fda warning letters glp-1 compounders october 2025 warns 30 telehealth firms over illegal sales FDA issued 25 warning letters

Without enough dietary protein and resistance training, lean muscle loss can occur during rapid weight loss

Our semaglutide sublingual suspension contains the same active ingredient as the injectable dosage forms, but compounded with different formulation to take by mouth under the tongue, and at a fraction of the cost of the injectable semaglutide

Furthermore, it exhibits anti-oxidative and anti-inflammatory effects by suppressing nuclear factor-kappa B (NF-B) activation, reducing inflammatory cytokines, and increasing the anti-inflammatory cytokine interleukin-10

These effects are linked to how GLP-1s can affect regions of the brain associated with reward-seeking and pleasure